Global real-world data can accelerate trials or quietly distort forecasts, inventory strategy, and regulatory decisions across clinical supply operations.
- How AI Can Solve Poor Communication Across Clinical Trial Supply Chains
- Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
- Managing Supply Disruptions In ATIMP Clinical Trials
- What Really Happens During A Temperature Excursion
- Want Faster FDA Release For Pharmaceutical Imports? Here's How.
- Decision Authority And Direction — The Gap In Deviation Planning
- Achieving Forecasting And Inventory Agility In A Volatile Clinical Trial Supply Environment
ON-DEMAND WEBINARS
This webinar brings together a panel of supply chain experts to bring insight into managing the uncertainty and risk that comes along with clinical supply decisions.
Explore how demand-led, decentralized clinical supply models are reshaping complex trials by reducing waste, accelerating timelines, and advancing patient-centric access to investigational therapies.
Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.
Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![BO 2 - GC_App_^CZ vial with stopper and seal stack up]( "Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization")
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To CommercializationWhile in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
![GettyImages-1331571740-supply-chain-sourcing-logistics-tracking]( "The Dual Sourcing Approach")
The Dual Sourcing ApproachHaving a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
-
![An Insider’s Guide To Interactive Response Technology (IRT) For Clinical Trials]( "Modern Architecture's Impact On UX In Next-Gen Interactive Response Tech")
Modern Architecture's Impact On UX In Next-Gen Interactive Response TechExplore how Interactive Response Technologies (IRTs) built around microservices models can provide faster initial builds, more rapid change management, and improved built-in test automation.
-
![cell-gene-therapy-GettyImages-2157300524]( "FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study")
FastChain®: A Solution For Made-To-Order Gene Replacement Therapy StudyAdopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.
-
![West Pharma]( "Key Considerations For Packaging Solutions For Cell And Gene Therapies")
Key Considerations For Packaging Solutions For Cell And Gene TherapiesThinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.
-
![GettyImages-980809416 clinical supply]( "Common RTSM/IRT AN Medication Pooling Questions Answered")
Common RTSM/IRT AN Medication Pooling Questions AnsweredWhether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.
-
![analytical-timelines-GettyImages-2247278213]( "Compressing Analytical Timelines Without Cutting Corners")
Compressing Analytical Timelines Without Cutting CornersEfficient analytical development speeds decisions and improves risk visibility. Using QbD, digital tools, and strong communication helps teams accelerate timelines while maintaining rigor.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Outgrowing Excel: Implementing RTSM In A Live Phase I Trial")
Outgrowing Excel: Implementing RTSM In A Live Phase I TrialLearn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
-
![Doctors discussing patient data-GettyImages-2214031965]( "Building Better Resilience Into Your Clinical Supply Strategy")
Building Better Resilience Into Your Clinical Supply StrategyReliable clinical supply requires proper vendor selection, cross-functional communication, and safety nets built to accommodate an ever-changing geopolitical and global pharmaceutical landscape. To avoid supply disruptions for clinical drugs, sponsors must give clinical supply its proper weight in initial protocol development and trial design.
-
![iStock-649856194-doctor-packaging-trial]( "Logistics, Transport Challenges Require Complex Solutions")
Logistics, Transport Challenges Require Complex SolutionsThe pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
